Company Filing History:
3 out of 9 
1 out of 5 Years Active: 2010-2022
Title: Shijun Zhang: Innovator in Pharmaceutical Research
Introduction
Shijun Zhang is a prominent inventor based in Tianjin, China. He has made significant contributions to the field of pharmaceutical research, particularly in the development of innovative compounds for medical applications. With a total of four patents to his name, Zhang's work focuses on addressing critical health issues through novel chemical solutions.
Latest Patents
Zhang's latest patents include groundbreaking inventions such as "Thienopyridine derivatives containing unsaturated aliphatic olefinic bond, preparation method and use thereof." This invention presents a compound designed to combat clopidogrel resistance and mitigate severe hemorrhagic side effects associated with certain drugs. The compound's solid form enhances stability and therapeutic efficacy, making it a promising candidate for ADP receptor antagonist antiplatelet agents.
Another notable patent is "Phenyl C-glucoside derivatives, preparation methods and uses thereof." This invention relates to a sodium glucose cotransporter 2 (SGLT2) inhibitor, which is crucial in treating diabetes. The patent outlines the preparation method and pharmaceutical compositions that can be utilized in developing effective anti-diabetes medications.
Career Highlights
Shijun Zhang has worked at esteemed institutions such as the Tianjin Institute of Pharmaceutical Research and Tianjin Institute of Pharmaceutical Research Co., Ltd. His experience in these organizations has allowed him to collaborate with other experts in the field and contribute to significant advancements in pharmaceutical science.
Collaborations
Zhang has collaborated with notable colleagues, including Weiren Xu and Lida Tang. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in pharmaceutical research.
Conclusion
Shijun Zhang's contributions to pharmaceutical research through his innovative patents highlight his commitment to improving healthcare solutions. His work continues to pave the way for advancements in the treatment of critical health conditions.